Expression, purification, and in vitro refolding of a humanized single-chain Fv antibody against human CTLA4 (CD152)

Protein Expression and Purification

Volumn 46, Issue 2, 2006, Pages 495-502

  Chen, Li Hong ^a   Huang, Qiang ^a   Wan, Lin ^a   Zeng, Ling Yu ^b   Li, Sheng Fu ^a   Li, You Ping ^a   Lu, Xiao Feng ^a   Cheng, Jing Qiu ^a  

^a SICHUAN UNIVERSITY   (China)

^b Department of Hematology   (China)

Author keywords

Bacterial expression; CTLA4; In vitro refolding; Single chain Fv antibody

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 33645420672     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2005.09.002     Document Type: Article

References (27)

1. J.F. Brunet, F. Denizot, M.F. Luciani, M. Roux-Dosseto, M. Suzan, M.G. Mattei, and P. Golstein A new member of the immunoglobulin superfamily, CTLA-4 Nature 328 1992 267 270
2. C.A. Chambers, and J.P. Allison Costimulatory regulation of T cell function Curr. Opin. Cell Biol. 11 1999 203 210
3. D.M. Samson CD28, CTLA-4 and their ligand: who does what and to whom? Immunology 101 2000 169
4. M.L. Alegre, P.J. Noel, B.J. Eisefelder, E. Chuang, M.R. Clark, S.L. Reiner, and C.B. Thompson Regulation of surface and intracellular expression of CTLA-4 on mouse T cells J. Immunol. 157 1996 4762
5. D.J. Lenschow, Y. Zeng, J.R. Thistlewaite, A. Montag, W. Brady, M.G. Gibson, P.S. Linsley, and J.A. Bluestone Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA-4Ig Science 257 1992 789
6. E.A. Tivol, S.D. Boyd, S.M. Keon, F. Borriello, P. Nickerson, T.B. Strom, and A.H. Sharpe CTLA-4-Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4 deficient mice J. Immunol. 158 1997 5091
7. P.L. Tazzari, L. Polito, A. Bolognesi, M.P. Pistillo, P. Capanni, G.L. Palmisano, R.M. Lemoli, A. Curti, L. Biancone, G. Camussi, R. Conte, G.B. Ferrara, and F. Stirpe Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin: in vitro results and in vivo effects in an acute rejection model J. Immunol. 167 2001 4222 4229
8. J.S. Huston, D. Levinson, M. Mudgett-Hunter, M.S. Tai, J. Novotny, M.N. Margolies, R.J. Ridge, R.E. Bruccoleri, E. Haber, and R. Crea Protein engineering of antibody binding sites: recovery of specific activity in an antidigoxin single-chain Fv analogue produced in Escherichia coli Proc. Natl. Acad. Sci. 85 1988 5879 5883
9. A.A. Kortt, Q. Dolezal, B.E. Power, and P.J. Hudson Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting Biomol. Eng. 18 2001 98 108
10. M.L. Penichet, and S.L. Morrison Antibody-cytokine fusion proteins for the therapy of cancer J. Immunol. Methods 248 2001 91 101
11. G.P. Adams, C.C. Shaller, L.L. Chappell, C. Wu, E.M. Horak, H.H. Simmons, S. Litwin, J.D. Marks, L.M. Weiner, and M.W. Brechbiel Delivery of the alpha-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules Nucl. Med. Biol. 27 2000 339 346
12. R. Verma, E. Boleti, and A.J.T. George Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems J. Immunol. Methods 216 1998 165 181
13. M.P. Pistillo, P.L. Tazzari, J.H. Ellis, and G.B. Ferrara Molecular characterization and applications of recombinant scFv antibodies to CD152 co-stimulatory molecule Tissue Antigens 55 2000 229 238
14. C.T. Chung, and R.H. Niller A rapid and convenient method for the preparation and storage of competent bacterial cells Nucleic Acids Res. 16 1988 3580
15. U.K. Laemmli Cleavage of structural proteins during assembly of the head of bacteriophage T4 Nature 227 1970 680 685
16. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
17. M. Frederick Short Protocols in Molecular Biology 3rd ed. 1995 John Wiley
18. H. Lu, H. Zhang, Q. Wang, H. Yuan, W. He, Z. Zhao, and Y. Li Purification, refolding of hybrid hIFN-Kringle 5 expressed in Escherichia coli Curr. Microbiol. 42 2001 211 216
19. A. Knappik, and A. Pluckthun Engineered turns of a recombinant antibody improve its in vivo folding Protein Eng. 8 1995 81 89
20. J.M. Schoemaker, A.H. Brasnett, and F.A.O. Marstion Examination of calf prochymotrypsin accumulation in Escherichia coli: disulfide linkages are a structural component of prochymotrypsin-containing inclusion bodies EMBOJ 4 1985 775 780
21. J. Buchner, and R. Rudolph Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli Biotechnology 9 1991 157 162
22. J. Buchner, I. Pastan, and U. Brinkmann A method for increasing the yield of properly folded recombinant fusion proteins: single chain immunotoxins from renaturation of bacterial inclusion bodies Anal. Biochem. 205 1992 263 270
23. B. Fisher, I. Sumner, and P. Goodenough Isolation, renaturation, and formation of disulfide bonds of eucaryotic proteins expressed in E. coli as inclusion bodies Biotechnol. Bioeng. 41 1992 3 13
24. G. Stempfer, B. Holl-Neugebauer, and R. Rudolph Improved refolding of an immobilized fusion protein Nat. Biotechnol. 14 1996 329 334
25. D.L. Hevehan, and E.D.B. Clark Oxidative renaturation of lysozyme at high concentrations Biotechnol. Bioeng. 54 1997 221 230
26. D.B. Wetlaufer, P.A. Branca, and G. Chen The oxidative folding of proteins by disulfide plus thiol does not correlate with redox potential Protein Eng. 1 1987 141 146
27. Y. Xie, and D.B. Wetlaufer Control of aggregation in protein refolding: the temperature-leap tactic Protein Sci. 5 1996 517 523